Related Experiment Videos
Serum immunoglobulins to endotoxin core glycolipid: establishment of normal concentrations
S K Jackson1, J Parton, G Shortland
1University of Wales College of Medicine, Heath Park, Cardiff.
Insights
Infants have lower antibody levels to lipopolysaccharide (LPS) core glycolipid, especially preterm infants. This suggests anticore glycolipid immunoglobulin may help prevent Gram-negative infections in vulnerable infants.
Area of Science:
- Immunology
- Neonatal Medicine
- Pediatrics
Background:
- Lipopolysaccharide (LPS) core glycolipid is a key component of Gram-negative bacteria.
- Serum antibodies to LPS core glycolipid are important for immunity against Gram-negative infections.
- Immune system development and antibody production vary significantly in infants, particularly preterm infants.
Purpose of the Study:
- To measure serum antibody levels to LPS core glycolipid in normal children and term/preterm infants.
- To investigate the age-related development of these antibodies.
- To assess the potential therapeutic role of anticore glycolipid immunoglobulin in preventing Gram-negative infections in neonates.
Main Methods:
- Measurement of serum antibody titers to LPS core glycolipid.
- Comparison of antibody levels across different age groups: normal children, term infants, and preterm infants (categorized by weight and gestational age).
- Analysis of antibody class, predominantly IgG.
Main Results:
- Antilipopolysaccharide core glycolipid antibody was present in term infants and children, reaching adult levels by age 15.
- Antibodies were predominantly of the IgG class.
- Preterm infants (less than 32 weeks' gestation) exhibited significantly lower antibody titers compared to more mature infants.
Conclusions:
- Preterm infants have immature antibody responses to LPS core glycolipid.
- Lower antibody levels in preterm infants may increase their susceptibility to Gram-negative infections.
- Administration of anticore glycolipid immunoglobulin could be a potential strategy for preventing or treating Gram-negative sepsis in preterm and very young infants.
Abstract:
Serum antibody to lipopolysaccharide core glycolipid was measured in normal children and in full term and premature (less than or equal to 1500 g) infants. Antilipopolysaccharide core glycolipid antibody was present in term infants and normal children, and reached adult titres by 15 years of age. The specific anti core glycolipid antibody was predominately of the IgG class. Preterm infants (less than 32 weeks' gestation) had significantly lower titres of antilipopolysaccharide core glycolipid than more mature preterm or term infants. The results suggest that administration of anticore glycolipid immunoglobulin may be beneficial in the treatment or prevention of Gram negative septicaemia in preterm and very young infants.